David Moss
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, David Moss sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
David Moss: 7 sponsored US clinical trials, 3 recruiting.
David Moss sponsors 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Core Strengthening, with 1 trials.
Upper-quartile sponsor footprint
David Moss sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)
NCT07094282
Acupuncture for Chronic Pelvic Pain
NCT06388590
Novel Mental Health Therapies to Improve Military Readiness
NCT05887713
Improving Core Strength in the Warfighter With a Novel Device
NCT06797830
Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.
NCT04692597
Nightmare Rescripting and Rehearsal
NCT04529070
Accessible Acupuncture for the Warrior With Acute Low Back Pain
NCT04236908
Therapeutic Areas
What is open in the David Moss pipeline
3 recruiting of 7 indexed (43% open); 1 completed (14%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Core Strengthening (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
David Moss: open-pipeline peers nationwide
Peers matched on 7 registered trials and 43% open enrollment, not the therapeutic-area sidebar.
David Moss sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 43% open enrollment (± trial volume)
- Alphatec Spine · 43% recruiting · 7 trials
- Clarity Pharmaceuticals · 43% recruiting · 7 trials
- Colorado Center for Reproductive Medicine · 43% recruiting · 7 trials
- EyeBiotech · 43% recruiting · 7 trials
Related
What to do with this David Moss page
7 registered trials is a research-attention snapshot, not an endorsement of David Moss or any single study.
- 3 of David Moss's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Core Strengthening is the condition David Moss studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Core Strengthening trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
David Moss pipeline card: 7 registered trials from official public datasets.Report a data error.